234 related articles for article (PubMed ID: 20571340)
21. Parallelism of DOG1 expression with recurrence risk in gastrointestinal stromal tumors bearing KIT or PDGFRA mutations.
Rizzo FM; Palmirotta R; Marzullo A; Resta N; Cives M; Tucci M; Silvestris F
BMC Cancer; 2016 Feb; 16():87. PubMed ID: 26867653
[TBL] [Abstract][Full Text] [Related]
22. Discovered on gastrointestinal stromal tumours 1 (DOG1) expression in non-gastrointestinal stromal tumour (GIST) neoplasms.
Hemminger J; Iwenofu OH
Histopathology; 2012 Aug; 61(2):170-7. PubMed ID: 22571292
[TBL] [Abstract][Full Text] [Related]
23. Pancreatic expression of DOG1: a novel gastrointestinal stromal tumor (GIST) biomarker.
Ardeleanu C; Arsene D; Hinescu M; Andrei F; Gutu D; Luca L; Popescu LM
Appl Immunohistochem Mol Morphol; 2009 Oct; 17(5):413-8. PubMed ID: 19417627
[TBL] [Abstract][Full Text] [Related]
24. KIT-negative gastrointestinal stromal tumor of the abdominal soft tissue: a clinicopathologic and genetic study of 10 cases.
Yamamoto H; Kojima A; Nagata S; Tomita Y; Takahashi S; Oda Y
Am J Surg Pathol; 2011 Sep; 35(9):1287-95. PubMed ID: 21836495
[TBL] [Abstract][Full Text] [Related]
25. Expression of dog1 in low-grade fibromyxoid sarcoma: A study of 19 cases and review of the literature.
Vallejo-Benítez A; Rodríguez-Zarco E; Carrasco SP; Pereira-Gallardo S; Brugal Molina J; García-Escudero A; Robles Frías A; Marcilla D; González-Cámpora R
Ann Diagn Pathol; 2017 Oct; 30():8-11. PubMed ID: 28965630
[TBL] [Abstract][Full Text] [Related]
26. DOG1 immunoreactivity in uterine leiomyosarcomas.
Sah SP; McCluggage WG
J Clin Pathol; 2013 Jan; 66(1):40-3. PubMed ID: 23038686
[TBL] [Abstract][Full Text] [Related]
27. A CD117 and CD34 immunoreactive sarcoma masquerading as a gastrointestinal stromal tumor: diagnostic pitfalls of ancillary studies in sarcoma.
Riddle ND; Gonzalez RJ; Bridge JA; Antonia S; Bui MM
Cancer Control; 2011 Jul; 18(3):152-9. PubMed ID: 21666577
[TBL] [Abstract][Full Text] [Related]
28. Gastrointestinal stromal tumors: differential diagnosis.
Dow N; Giblen G; Sobin LH; Miettinen M
Semin Diagn Pathol; 2006 May; 23(2):111-9. PubMed ID: 17193824
[TBL] [Abstract][Full Text] [Related]
29. PDGFR expression in differential diagnosis between KIT-negative gastrointestinal stromal tumours and other primary soft-tissue tumours of the gastrointestinal tract.
Rossi G; Valli R; Bertolini F; Marchioni A; Cavazza A; Mucciarini C; Migaldi M; Federico M; Trentini GP; Sgambato A
Histopathology; 2005 May; 46(5):522-31. PubMed ID: 15842634
[TBL] [Abstract][Full Text] [Related]
30. A KIT-negative, DOG1-positive epithelioid GIST of the stomach harboring a novel PDGFRA exon 14 single nucleotide deletion.
Rizzardi C; Marzinotto S; Avellini C; Melato M; Mariuzzi L
Anticancer Res; 2012 May; 32(5):1775-8. PubMed ID: 22593460
[TBL] [Abstract][Full Text] [Related]
31. Gastrointestinal Kaposi's sarcoma: CD117 expression and the potential for misdiagnosis as gastrointestinal stromal tumour.
Parfitt JR; Rodriguez-Justo M; Feakins R; Novelli MR
Histopathology; 2008 Jun; 52(7):816-23. PubMed ID: 18494611
[TBL] [Abstract][Full Text] [Related]
32. Expression of DOG1, CD117 and PDGFRA in gastrointestinal stromal tumors and correlations with clinicopathology.
Sui XL; Wang H; Sun XW
Asian Pac J Cancer Prev; 2012; 13(4):1389-93. PubMed ID: 22799337
[TBL] [Abstract][Full Text] [Related]
33. DOG1 Expression in Low-Grade Fibromyxoid Sarcoma: A Study of 11 Cases, With Molecular Characterization.
Thway K; Ng W; Benson C; Chapman J; Fisher C
Int J Surg Pathol; 2015 Sep; 23(6):454-60. PubMed ID: 26135531
[TBL] [Abstract][Full Text] [Related]
34. Old and new immunohistochemical markers for the diagnosis of gastrointestinal stromal tumors.
González-Cámpora R; Delgado MD; Amate AH; Gallardo SP; León MS; Beltrán AL
Anal Quant Cytol Histol; 2011 Feb; 33(1):1-11. PubMed ID: 22125840
[TBL] [Abstract][Full Text] [Related]
35. KIT immunohistochemistry and mutation status in gastrointestinal stromal tumours (GISTs) evaluated for treatment with imatinib.
Loughrey MB; Trivett M; Beshay V; Dobrovic A; Kovalenko S; Murray W; Lade S; Turner H; McArthur GA; Zalcberg J; Waring PM
Histopathology; 2006 Jul; 49(1):52-65. PubMed ID: 16842246
[TBL] [Abstract][Full Text] [Related]
36. Functional role of the Ca²⁺-activated Cl⁻ channel DOG1/TMEM16A in gastrointestinal stromal tumor cells.
Berglund E; Akcakaya P; Berglund D; Karlsson F; Vukojević V; Lee L; Bogdanović D; Lui WO; Larsson C; Zedenius J; Fröbom R; Bränström R
Exp Cell Res; 2014 Aug; 326(2):315-25. PubMed ID: 24825187
[TBL] [Abstract][Full Text] [Related]
37. Utility of DOG1 Immunomarker in Fine Needle Aspirates of Gastrointestinal Stromal Tumor.
Kakkar A; Mathur SR; Jain D; Iyer VK; Nalwa A; Sharma MC
Acta Cytol; 2015; 59(1):61-7. PubMed ID: 25632981
[TBL] [Abstract][Full Text] [Related]
38. Discovered on gastrointestinal stromal tumor 1, a keystone in the diagnosis of extraintestinal gastrointestinal stromal tumors.
Sahu KK; Tapadia R; Kini JR; Pai RR; Kini H; Nirupama M; Pooja KS
J Cancer Res Ther; 2019; 15(1):138-141. PubMed ID: 30880769
[TBL] [Abstract][Full Text] [Related]
39. DOG1 (clone K9) is seldom expressed and not useful in the evaluation of pancreatic neoplasms.
Hemminger J; Marsh WL; Iwenofu OH; Frankel WL
Appl Immunohistochem Mol Morphol; 2012 Jul; 20(4):397-401. PubMed ID: 22495382
[TBL] [Abstract][Full Text] [Related]
40. Gastrointestinal stromal tumors (GISTs): CD117, DOG-1 and PKCθ expression. Is there any advantage in using several markers?
Ríos-Moreno MJ; Jaramillo S; Pereira Gallardo S; Vallejo A; Mora M; García-Escudero A; Amérigo J; González-Cámpora R
Pathol Res Pract; 2012 Feb; 208(2):74-81. PubMed ID: 22197035
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]